Kiniksa Pharmaceuticals International, plc
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $-89.7M | $45.6M |
| FY2018 | — | $279.3M | $72.0M |
| FY2019 | — | $225.4M | $46.9M |
| FY2020 | — | $311.9M | $114.0M |
| FY2021 | — | $185.0M | $122.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $-89.7M | $45.6M |
| FY2018 | — | $279.3M | $72.0M |
| FY2019 | — | $225.4M | $46.9M |
| FY2020 | — | $311.9M | $114.0M |
| FY2021 | — | $185.0M | $122.5M |